ESR1 and cervical carcinoma: An adenovirus expressing a dominant-negative estrogen receptor gene (Ad-ER-DN) to block estrogen receptors, has been used in CaSki cervical cancer cells, achieving reduction in the expression of E6 and E7 oncogenes, blocking cell proliferation and inducing apoptosis [50].